US FTC Pulling Various Levers To Impose Monetary Relief On False Ad Defendants
The Federal Trade Commission is leveraging other statutory authorities under the FTC Act and working with state regulators to garner monetary relief for consumers in the year since a Supreme Court decision shut down the commission’s longtime pathway for doing so under Sec. 13(b). FTC Bureau of Consumer Protection director Samuel Levine provided an update – and a warning to industry – at the NAD 2022 conference.
You may also be interested in...
The US Federal Trade Commission is "fully prepared" to bring forward cases after issuing hundreds of penalty offense notices in April regarding health claims substantiation, and it is likely to seek injunctive and monetary relief, said Samuel Levine, director of the FTC’s Bureau of Consumer Protection, at the National Advertising Division’s annual conference in Philadelphia.
‘Akin To Junk Mail,’ FTC Notices Of Penalty Offense Don't Identify Health Claim Violations – Petition
Trade group ask FTC to withdraw notices, arguing it is attempting to impose substantiation standard prohibited under FDA regulations for supplement manufacturing and marketing and are inconsistent with its own as well as FDA guidance
Agency sends flares across wide field of advertisers illuminating the need for marketers to substantiate health claims. Reminder made brighter noting penalties of up to $50,120 per violation.